# Stereotactic Radiotherapy for Oligometastatic Prostate Cancer

> **NCT02563691** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 90 (actual)

## Conditions studied

- Prostatic Neoplasms

## Interventions

- **RADIATION:** stereotactic radiotherapy

## Key facts

- **NCT ID:** NCT02563691
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-11
- **Primary completion:** 2021-12
- **Final completion:** 2022-12
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2022-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02563691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02563691, "Stereotactic Radiotherapy for Oligometastatic Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02563691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*